Valentina Butta
Overview
Explore the profile of Valentina Butta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riva G, Cilibrasi C, Bazzoni R, Cadamuro M, Negroni C, Butta V, et al.
Genes (Basel)
. 2018 Oct;
9(11).
PMID: 30373123
Glioblastoma is the most common malignant brain tumour in adults. The failure of current therapies can be ascribed to glioma stem cells (GSCs), which can rapidly repopulate the tumour following...
2.
Riva G, Baronchelli S, Paoletta L, Butta V, Biunno I, Lavitrano M, et al.
Toxicol Rep
. 2017 Oct;
1:188-199.
PMID: 28962238
Glioblastoma multiforme (GBM) is a grade IV astrocytoma and the most common malignant brain tumor. Current therapies provide a median survival of 12-15 months after diagnosis, due to the high...
3.
Cilibrasi C, Riva G, Romano G, Cadamuro M, Bazzoni R, Butta V, et al.
PLoS One
. 2017 Jan;
12(1):e0169854.
PMID: 28081224
Glioblastoma multiforme (GBM) is a grade IV astrocytoma and the most common form of malignant brain tumor in adults. GBM remains one of the most fatal and least successfully treated...
4.
Cilibrasi C, Butta V, Riva G, Bentivegna A
PPAR Res
. 2016 Jun;
2016:7175067.
PMID: 27313600
Glioblastoma multiforme (GBM) represents one of the most frequent malignant brain tumors. Current therapies do not provide real solutions to this pathology. Their failure can be ascribed to a cell...
5.
Riva G, Butta V, Cilibrasi C, Baronchelli S, Redaelli S, Dalpra L, et al.
Oncol Rep
. 2016 Mar;
35(5):2811-24.
PMID: 26986767
Glioblastoma (GBM) is the most aggressive tumor of the central nervous system. GBM is a fatal tumor, incurable by conventional therapies. One of the factors underlying tumor recurrence and poor...
6.
Bentivegna A, Miloso M, Riva G, Foudah D, Butta V, Dalpra L, et al.
Stem Cells Int
. 2013 Nov;
2013:192425.
PMID: 24288545
Mesenchymal stem cells (MSCs) hold great promise for the treatment of numerous diseases. A major problem for MSC therapeutic use is represented by the very low amount of MSCs which...
7.
Baronchelli S, Bentivegna A, Redaelli S, Riva G, Butta V, Paoletta L, et al.
PLoS One
. 2013 Mar;
8(2):e57462.
PMID: 23468990
Glioblastoma multiforme (GBM), the most common and malignant type of glioma, is characterized by a poor prognosis and the lack of an effective treatment, which are due to a small...